Last update 21 Nov 2024

AML Cell Vaccine(Kings College London)

Overview

Basic Info

Drug Type
Therapeutic vaccine
Synonyms-
Target-
Mechanism
Immunostimulants
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Originator Organization
King's College LondonKing's College London
Active Organization-
Inactive Organization
King's College LondonKing's College LondonKing's College Hospital NHS Foundation TrustKing's College Hospital NHS Foundation Trust
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with AML Cell Vaccine(Kings College London)
NCT02493829 / Unknown statusPhase 1
A Phase I Study of B7.1 (CD80)/IL-2 Immune Gene Therapy for High Risk MDS RAEB-2 and Acute Myeloid Leukaemia Patients Unsuitable for Allogeneic Haematological Stem Cell Transplant
100 Clinical Results associated with AML Cell Vaccine(Kings College London)
Login to view more data
100 Translational Medicine associated with AML Cell Vaccine(Kings College London)
Login to view more data
100 Patents (Medical) associated with AML Cell Vaccine(Kings College London)
Login to view more data
100 Deals associated with AML Cell Vaccine(Kings College London)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPhase 1-
King's College LondonKing's College London
01 May 2017
Acute Myeloid LeukemiaPhase 1-
King's College Hospital NHS Foundation TrustKing's College Hospital NHS Foundation Trust
01 May 2017
Myelodysplastic SyndromesPhase 1-
King's College LondonKing's College London
01 May 2017
Myelodysplastic SyndromesPhase 1-
King's College Hospital NHS Foundation TrustKing's College Hospital NHS Foundation Trust
01 May 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free